Voxsanity

Who may be able to join

Here is the eligibility information explained in plain language:

Who might be able to join this trial:

You are currently taking a medication called mesalamine, and you are willing to switch to a different brand of it for 4 months (or you are already taking the brand called Asacol or Asacol HD).
You have not taken any steroid medications in the last 3 months.
You are able to travel to MGH hospital for a total of 6 visits.

Who may not be able to join:

You are not currently taking mesalamine, or you are not willing to switch to a different brand of it for 4 months.
You are currently taking steroid medications, or you have taken them at any point in the last 3 months.
You are unable to attend 6 visits at MGH hospital.
You have had a vasectomy, or it has been medically confirmed that you are infertile.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status

Completed

Phase

Not Applicable

Sponsor

Harvard School of Public Health (HSPH)

Registry

clinicaltrials_gov

Start date

1 May 2010

Est. completion

1 August 2018

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Altered semen quality and sperm transcriptome analysis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov